Trupanion, Inc. (NASDAQ:TRUP) Receives Consensus Rating of “Moderate Buy” from Analysts

Trupanion, Inc. (NASDAQ:TRUP) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $44.67.

TRUP has been the subject of a number of research analyst reports. Piper Sandler raised their target price on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday. William Blair started coverage on shares of Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating for the company. Stifel Nicolaus lifted their price objective on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Bank of America upped their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Finally, Northland Securities lifted their price target on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday.

Trupanion Price Performance

NASDAQ TRUP opened at $54.78 on Friday. The firm’s fifty day simple moving average is $46.92 and its two-hundred day simple moving average is $36.00. The firm has a market capitalization of $2.31 billion, a P/E ratio of -171.19 and a beta of 1.73. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion has a 12-month low of $19.14 and a 12-month high of $57.90.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. The company had revenue of $327.50 million for the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. Trupanion’s revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.10) EPS. Analysts forecast that Trupanion will post -0.34 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders sold a total of 8,764 shares of company stock worth $405,238 in the last 90 days. Insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

A number of large investors have recently modified their holdings of TRUP. GAMMA Investing LLC lifted its stake in shares of Trupanion by 70.4% in the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after buying an additional 596 shares in the last quarter. Headlands Technologies LLC purchased a new position in Trupanion in the 2nd quarter worth approximately $162,000. Oppenheimer Asset Management Inc. purchased a new position in Trupanion in the 2nd quarter worth approximately $235,000. Handelsbanken Fonder AB acquired a new position in shares of Trupanion during the 3rd quarter worth approximately $248,000. Finally, Bayesian Capital Management LP purchased a new stake in shares of Trupanion in the first quarter valued at approximately $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.